Design and created by Guideline Central in participation with the American Academy of Otolaryngology - Head and Neck Surgery Foundation.
American Academy of Otolaryngology - Head and Neck Surgery Foundation
Publication Date:
The purpose of this patient summary is to provide guidance on the diagnosis, management, and follow-up of sudden hearing loss. It focuses on sudden idiopathic sensorineural hearing loss in adult patients aged 18 years and older, and mainly on sudden sensorineural hearing loss with no obvious known cause.
Cause: Infection (viral including herpes simplex virus [HSV], varicella zoster virus [VZV], human immunodeficiency virus [HIV] and others — bacteria, mycoplasma, Lyme disease, tuberculosis, syphilis, fungal)
Other Features: Headache, fever, other cranial nerve palsies, abnormal cerebrospinal fluid (CSF) commonly seen in meningitis. pinna or ear canal vesicles and facial weakness are often seen in VZV (Ramsay Hunt Syndrome/Herpes Zoster Oticus).
Cause: Autoimmune inner ear disease
Other Features: Hearing fluctuation, vertigo
Cause: Ototoxic Medication
Other Features: Vestibular loss, oscillopsia
Cause: Trauma
Other Features: Temporal bone fracture with possible Battle’s sign, cochlear concussion without visible fracture, barotrauma
Cause: Lead poisoning
Other Features: Learning disabilities, other stigmata of lead poisoning
Cause: Genetic Disorders
Other Features: May be syndromic or non-syndromic and may present later in life
Cause: Mitochondrial Disorders including MELAS (Metabolic Encephalopathy, Lactic Acidosis and Stroke-like episodes) and others
Other Features: Confusion, stroke like spells, elevated lactate, MRI white matter changes, others with variable phenotypes
Cause: Stroke
Other Features: Vertigo, dysarthria, facial weakness, ataxia, nystagmus, unilateral numbness, abnormal CT or MRI or MR angiogram of the vertebro-basilar vasculature
Cause: Cogan’s syndrome
Other Features: Non-syphilitic interstitial keratitis of the cornea, hearing loss, vertigo
Cause: Neoplastic (neurofibromatosis II, bilateral vestibular schwannomas, carcinomatous meningitis, intravascular lymphomatosis, others)
Other Features: Abnormal brain MRI, cerebrovascular imaging study, or CSF
Cause: Sarcoidosis
Other Features: Pulmonary symptoms, bilateral vestibular loss, elevated angiotensin converting enzyme (ACE) level, abnormal gallium scan
Cause: Hyperviscosity syndrome
Other Features: Mucous membrane bleeding, neurologic and pulmonary symptoms, associated retinopathy
Timing of Treatment: Immediate, ideally within the first 14 days. Benefit has been reported up to six weeks post onset of symptoms.
Dose: Prednisone 1 mg/kg/day (usual maximal dose is 60 mg/day) or Methylprednisolone 48 mg/day or Dexamethasone 10 mg/day
Duration/Frequency: Full dose for seven to 14 days, then taper over a similar time period.
Technique: Do not divide doses
Monitoring: Audiogram at completion of treatment course and at delayed intervals
Modifications: Medically treat significant adverse drug reactions, such as insomnia
Monitor for hyperglycemia, hypertension in susceptible patients.
Timing of Treatment: Immediate; Salvage (rescue) after initial treatment fails or after 2 weeks from symptom onset
Dose: Dexamethasone 24 mg/mL (compounded), or 10 mg/mL (stock) if compounded concentration unavailable or Methylprednisolone 40 mg/mL or 30 mg/mL
Duration/Frequency: Inject 0.4 to 0.8 mL into middle ear space up to four injections over a two-week period
Technique: Fill the middle ear with steroid solution. Keep head in otologic position (one side down, affected ear up) for 15–30 minutes.
Monitoring: Audiogram at completion of treatment course and at delayed intervals. Interval audiograms between injections may help direct early termination of therapy if hearing loss resolves. Inspect tympanic membrane to ensure healing at completion of treatment course, and at a delayed interval.
Modifications: May insert pressure-equalizing tube if planning multiple injections, but this increases risk of tympanic membrane perforation.
Chandrasekhar SS, Tsai Do BS, Schwartz SR, et al. Clinical Practice Guideline: Sudden Hearing Loss (Update). Otolaryngol Head Neck Surg. 2019;161 (1_Suppl):[S1-S45].
The information in this patient summary should not be used as a substitute for professional medical care or advice. Contact a health care provider if you have questions about your health.
Guideline Central and select third party use “cookies” on this website to enhance the user experience.
This technology helps us gather statistical and analytical information to optimize the relevant content for you.
The user also has the option to opt-out which may have an effect on the browsing experience.